Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John T. Cavan currently holds 14,800 shares of Hepion Pharmaceuticals, Inc. (HEPA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John T. Cavan has been a net buyer of HEPA stock. They have purchased $40.3K and sold $0 worth of shares.
John T. Cavan's most recent insider trade was on Feb 18, 2021, when they purchased 10,000 shares at $2.00 per share.
John T. Cavan serves as Executive at Hepion Pharmaceuticals, Inc. (HEPA). They have executed 5 insider transactions totaling $40.3K over their tenure at the company.
John T. Cavan holds the position of Executive at Hepion Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
John T. Cavan has shown a buying trading pattern, with $40.3K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by John T. Cavan was on Feb 18, 2021, when they purchased $20.0K worth of HEPA shares. This transaction involved 10,000 shares at $2.00 per share.
John T. Cavan currently owns 14,800 shares of Hepion Pharmaceuticals, Inc. (HEPA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John T. Cavan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John T. Cavan has 5 Form 4 filings on record as an insider at Hepion Pharmaceuticals, Inc..
Set alerts for John T. Cavan and 40,000+ other insiders.